SCHEMBL4904475

SCHEMBL4904475

CCc1ccc(S(=O)(=O)N(CC)c2nc(-c3ccc(Cl)cc3)sc2C)cc1C(=O)O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.42
KMT2A Q03164 4/20 0.42
MEN1 O00255 3/20 0.42
PSEN1 P49768 2/20 0.41
PSEN2 P49810 2/20 0.41
APH1B Q8WW43 2/20 0.41
NCSTN Q92542 2/20 0.41
APH1A Q96BI3 2/20 0.41
PSENEN Q9NZ42 2/20 0.41
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 1/20 0.39
TRPM8 Q7Z2W7 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4906621 0.92 ALDH1A1 (0.43) LMNAKMT2AMEN1PSEN1PSEN2
SCHEMBL4904159 0.91 MEN1 (0.52) LMNAKMT2AMEN1PSEN1PSEN2
SCHEMBL4902506 0.91 LMNA (0.43) LMNAKMT2AMEN1PSEN1PSEN2
SCHEMBL4905616 0.91 LMNA (0.46) LMNAKMT2AMEN1PSEN1PSEN2
SCHEMBL4906118 0.91 LMNA (0.44) LMNAKMT2AALDH1A1HPGDALOX15
SCHEMBL4895731 0.90 ALDH1A1 (0.44) LMNAKMT2AMEN1PSEN1PSEN2
SCHEMBL4906402 0.89 LMNA (0.39) LMNAKMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL4904191 0.88 LMNA (0.42) LMNAKMT2AMEN1PSEN1PSEN2
SCHEMBL4899415 0.88 MEN1 (0.41) LMNAKMT2AMEN1KDM4ENPC1
SCHEMBL4904359 0.87 KDM4E (0.40) LMNAKMT2AMEN1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PFIZER INC. 2008-04-17 US disclosed
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288340-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD LMNA 319/4885KMT2A 3530/4885MEN1 4855/4885
US-20080090829-A1 SUBSTITUTED HETEROARYL- AND PHENYLSULFAMOYL COMPOUNDS PPARA, PPARG, PPARD LMNA 319/4885KMT2A 3530/4885MEN1 4855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.